Blood Test May Predict Who Ages Healthier, Study Finds

Scientists may have found a way to predict who will age gracefully and who will face chronic disease, all from a simple blood test.

Researchers at Washington University in St. Louis discovered that the balance of two specific immune cell types can reveal a lot about how someone will age. The finding, published in the journal Immunity, analyzed data from nearly 51,000 people and found clear patterns linking immune health to long-term wellness.

The discovery focuses on memory T cells, white blood cells that remember past infections and help fight them off faster next time. These cells make different proteins called granzymes that kill infected cells, with two main types: granzyme K and granzyme B.

People with more granzyme B-making cells compared to granzyme K cells showed higher risks of autoimmune diseases and chronic conditions. When researchers tracked nearly 48,000 participants in the UK Biobank for 17 years, those predicted to have higher granzyme B levels faced worse health outcomes, including increased risk of diabetes, high blood pressure, liver disease, kidney disease, and earlier death.

The team first noticed this pattern in older adults and lab mice, where certain immune cells accumulated with age and linked to inflammation. The new study connected these observations to real health outcomes over nearly two decades.

"In the future, the balance of cells making granzyme K and granzyme B in a person's blood could be used as a test to determine whether you're on the right trajectory of aging or not," study co-author Maxim Artyomov told Live Science.

Why This Inspires

This discovery opens doors scientists didn't know existed. Understanding the immune system's role in healthy aging could lead to early interventions that help people stay well longer, rather than just treating diseases after they appear.

The research also revealed important differences between mouse and human immune systems that weren't fully understood before, which could improve future medical studies. Immunologist Claire Gustafson from the Allen Institute, who wasn't involved in the study, called the findings "really exciting" and said they highlight "potentially some novel biology that we haven't really observed before."

The researchers caution that while the association between cell balance and health is strong, they haven't proven the ratio directly causes poor outcomes. More studies are needed to understand exactly why having more granzyme B cells connects to worse health, and whether changing this balance could actually improve aging outcomes.

Still, identifying a measurable marker of healthy aging represents real progress toward helping people live not just longer, but better.